Charles River Laboratories International PE ratio CRL

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 19.0×; Feb 2025
10-year median: 29.3×
10-year range: 18.3× to 59.1×
Peer median: 39.3×

Charles River Laboratories International has no meaningful PE ratio today: it lost $4.85 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Feb 2025, at 19.0×.

On the days it had one over the last ten years, its median was 29.3×, from 18.3× in Oct 2023 to 59.1× in Sep 2021.

PE ratio over time

median 29.3×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2025	19.0×	19.0×	23.2×
2024	23.2×	21.6×	29.5×
2023	25.6×	18.3×	29.5×
2022	25.7×	21.8×	45.9×
2021	48.7×	38.0×	59.1×
2020	41.6×	20.9×	46.2×
2019	32.6×	27.0×	45.3×
2018	40.3×	24.3×	51.2×
2017	26.7×	24.7×	30.9×
2016	25.7×	23.0×	28.9×
2015	31.1×	25.7×	33.8×
2014	25.8×	22.4×	28.6×
2013	25.3×	17.8×	25.6×
2012	16.8×	15.3×	19.1×

Against its peers

Companies in Medical - Diagnostics & Research nearest Charles River Laboratories International's size, closest first, today.

Company	PE ratio
CRLCharles River Laboratories International	n/m
RVTYRevvity	75.6×
MEDPMedpace	39.2×
LHLabcorp	27.2×
DGXQuest Diagnostics	25.7×
BIOBio-Rad Laboratories	44.8×
CAICaris Life Sciences	86.5×
MTDMettler-Toledo International	37.6×
ILMNIllumina	50.1×
LNTHLantheus	24.2×
IDXXIDEXX Laboratories	39.4×
Peer median	39.3×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Charles River Laboratories International

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.